Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

Date
2017
Author
Yenerel, Mustafa Nuri
Yonal-Hindilerden, Ipek
Hindilerden, Fehmi
Diz-Kucukkaya, Reyhan
Nalcaci, Meliha
Metadata
Show full item record
Abstract
Objective: This paper prospectively evaluates the long-term follow-up [mean +/- standard deviation (SD) duration: 89.7 +/- 19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab.
URI
http://hdl.handle.net/20.500.12627/27815
https://doi.org/10.4274/tjh.2016.0086
Collections